Search by Drug Name or NDC
NDC 52454-0001-03 Fonow 500; 40; 3.5; 5000 [iU]/g; mg/g; mg/g; [iU]/g Details
Fonow 500; 40; 3.5; 5000 [iU]/g; mg/g; mg/g; [iU]/g
Fonow is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Zhejiang Fonow Medicine Co., Ltd.. The primary component is BACITRACIN; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.
Product Information
| NDC | 52454-0001 |
|---|---|
| Product ID | 52454-001_ff3b8c57-c65e-7c3f-e053-6394a90a937e |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fonow |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bacitracin, Neomycin, Polymyxin B, Lidocaine HCL |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 500; 40; 3.5; 5000 |
| Active Ingredient Units | [iU]/g; mg/g; mg/g; [iU]/g |
| Substance Name | BACITRACIN; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Labeler Name | Zhejiang Fonow Medicine Co., Ltd. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Antiarrhythmic [EPC], Decreased Cell Wall Synthesis & Repair [PE], Local Anesthesia [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part333B |
| Listing Certified Through | 2024-12-31 |
Package
NDC 52454-0001-03 (52454000103)
| NDC Package Code | 52454-001-03 |
|---|---|
| Billing NDC | 52454000103 |
| Package | 25 POUCH in 1 BOX (52454-001-03) / 1 g in 1 POUCH |
| Marketing Start Date | 2018-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |